English
简体中文
Total: £ 56.28
Published Date: 2025-04-24 | Pages: 76 | Tables: 76 | Pharma & Healthcare
The global Targeted RNA Sequencing market size was US$ 2694 million in 2024 and is forecast to a readjusted size of US$ 10950 million by 2031 with a CAGR of 22.5% during the forecast period 2025-2031.
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
In the report, we only collect information about the companies who can provide targeted RNA sequencing service.
Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, with about 52% market shares.
North America is the largest consumption place, with a consumption market share nearly 32%. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.
The global Targeted RNA Sequencing market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
By Type: (Dominant Segment vs High-Margin Innovation)
Exome Sequencing
Enrichment Sequencing
Amplicon Sequencing
By Application: (Core Demand Driver vs Emerging Opportunity)
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Thermo Fisher in Europe)
- Emerging Product Trends: Exome Sequencing adoption vs. Enrichment Sequencing premiumization
- Demand-Side Dynamics: Research Institutes growth in China vs. Hospitals & Clinics potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
South Korea
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Targeted RNA Sequencing market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Enrichment Sequencing in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Hospitals & Clinics in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Targeted RNA Sequencing value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Exome Sequencing
1.2.3 Enrichment Sequencing
1.2.4 Amplicon Sequencing
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Research Institutes
1.3.3 Hospitals & Clinics
1.3.4 Biotechnology Company
1.3.5 Diagnostic Lab
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted RNA Sequencing Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Targeted RNA Sequencing Revenue Market Share by Region (2020-2025)
2.4 Global Targeted RNA Sequencing Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Targeted RNA Sequencing Market Size and Prospective (2020-2031)
2.5.2 Europe Targeted RNA Sequencing Market Size and Prospective (2020-2031)
2.5.3 China Targeted RNA Sequencing Market Size and Prospective (2020-2031)
2.5.4 Japan Targeted RNA Sequencing Market Size and Prospective (2020-2031)
2.5.5 South Korea Targeted RNA Sequencing Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Targeted RNA Sequencing Historic Market Size by Type (2020-2025)
3.2 Global Targeted RNA Sequencing Forecasted Market Size by Type (2026-2031)
3.3 Different Types Targeted RNA Sequencing Representative Players
4 Breakdown Data by Application
4.1 Global Targeted RNA Sequencing Historic Market Size by Application (2020-2025)
4.2 Global Targeted RNA Sequencing Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Targeted RNA Sequencing Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Targeted RNA Sequencing Players by Revenue (2020-2025)
5.1.2 Global Targeted RNA Sequencing Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Targeted RNA Sequencing Revenue
5.4 Global Targeted RNA Sequencing Market Concentration Analysis
5.4.1 Global Targeted RNA Sequencing Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Targeted RNA Sequencing Revenue in 2024
5.5 Global Key Players of Targeted RNA Sequencing Head office and Area Served
5.6 Global Key Players of Targeted RNA Sequencing, Product and Application
5.7 Global Key Players of Targeted RNA Sequencing, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Targeted RNA Sequencing Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Targeted RNA Sequencing Market Size by Type (2020-2025)
6.1.2.2 North America Targeted RNA Sequencing Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Targeted RNA Sequencing Market Size by Application (2020-2025)
6.1.3.2 North America Targeted RNA Sequencing Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Targeted RNA Sequencing Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Targeted RNA Sequencing Market Size by Type (2020-2025)
6.2.2.2 Europe Targeted RNA Sequencing Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Targeted RNA Sequencing Market Size by Application (2020-2025)
6.2.3.2 Europe Targeted RNA Sequencing Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Targeted RNA Sequencing Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Targeted RNA Sequencing Market Size by Type (2020-2025)
6.3.2.2 China Targeted RNA Sequencing Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Targeted RNA Sequencing Market Size by Application (2020-2025)
6.3.3.2 China Targeted RNA Sequencing Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Targeted RNA Sequencing Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Targeted RNA Sequencing Market Size by Type (2020-2025)
6.4.2.2 Japan Targeted RNA Sequencing Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Targeted RNA Sequencing Market Size by Application (2020-2025)
6.4.3.2 Japan Targeted RNA Sequencing Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 South Korea Market: Players, Segments and Downstream
6.5.1 South Korea Targeted RNA Sequencing Revenue by Company (2020-2025)
6.5.2 South Korea Market Size by Type
6.5.2.1 South Korea Targeted RNA Sequencing Market Size by Type (2020-2025)
6.5.2.2 South Korea Targeted RNA Sequencing Market Share by Type (2020-2025)
6.5.3 South Korea Market Size by Application
6.5.3.1 South Korea Targeted RNA Sequencing Market Size by Application (2020-2025)
6.5.3.2 South Korea Targeted RNA Sequencing Market Share by Application (2020-2025)
6.5.4 South Korea Market Trend and Opportunities
7 Key Players Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Company Details
7.1.2 Thermo Fisher Business Overview
7.1.3 Thermo Fisher Targeted RNA Sequencing Introduction
7.1.4 Thermo Fisher Revenue in Targeted RNA Sequencing Business (2020-2025)
7.1.5 Thermo Fisher Recent Development
7.2 Illumina
7.2.1 Illumina Company Details
7.2.2 Illumina Business Overview
7.2.3 Illumina Targeted RNA Sequencing Introduction
7.2.4 Illumina Revenue in Targeted RNA Sequencing Business (2020-2025)
7.2.5 Illumina Recent Development
7.3 Roche Holdings
7.3.1 Roche Holdings Company Details
7.3.2 Roche Holdings Business Overview
7.3.3 Roche Holdings Targeted RNA Sequencing Introduction
7.3.4 Roche Holdings Revenue in Targeted RNA Sequencing Business (2020-2025)
7.3.5 Roche Holdings Recent Development
7.4 BGI
7.4.1 BGI Company Details
7.4.2 BGI Business Overview
7.4.3 BGI Targeted RNA Sequencing Introduction
7.4.4 BGI Revenue in Targeted RNA Sequencing Business (2020-2025)
7.4.5 BGI Recent Development
7.5 Eurofins
7.5.1 Eurofins Company Details
7.5.2 Eurofins Business Overview
7.5.3 Eurofins Targeted RNA Sequencing Introduction
7.5.4 Eurofins Revenue in Targeted RNA Sequencing Business (2020-2025)
7.5.5 Eurofins Recent Development
7.6 LabCorp
7.6.1 LabCorp Company Details
7.6.2 LabCorp Business Overview
7.6.3 LabCorp Targeted RNA Sequencing Introduction
7.6.4 LabCorp Revenue in Targeted RNA Sequencing Business (2020-2025)
7.6.5 LabCorp Recent Development
7.7 Berry Genomics
7.7.1 Berry Genomics Company Details
7.7.2 Berry Genomics Business Overview
7.7.3 Berry Genomics Targeted RNA Sequencing Introduction
7.7.4 Berry Genomics Revenue in Targeted RNA Sequencing Business (2020-2025)
7.7.5 Berry Genomics Recent Development
7.8 Macrogen
7.8.1 Macrogen Company Details
7.8.2 Macrogen Business Overview
7.8.3 Macrogen Targeted RNA Sequencing Introduction
7.8.4 Macrogen Revenue in Targeted RNA Sequencing Business (2020-2025)
7.8.5 Macrogen Recent Development
7.9 GENEWIZ
7.9.1 GENEWIZ Company Details
7.9.2 GENEWIZ Business Overview
7.9.3 GENEWIZ Targeted RNA Sequencing Introduction
7.9.4 GENEWIZ Revenue in Targeted RNA Sequencing Business (2020-2025)
7.9.5 GENEWIZ Recent Development
8 Targeted RNA Sequencing Market Dynamics
8.1 Targeted RNA Sequencing Industry Trends
8.2 Targeted RNA Sequencing Market Drivers
8.3 Targeted RNA Sequencing Market Challenges
8.4 Targeted RNA Sequencing Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Targeted RNA Sequencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Targeted RNA Sequencing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Targeted RNA Sequencing Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Targeted RNA Sequencing Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Targeted RNA Sequencing Revenue Share by Region (2020-2025)
Table 6. Global Targeted RNA Sequencing Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Targeted RNA Sequencing Revenue Share Forecast by Region (2026-2031)
Table 8. Global Targeted RNA Sequencing Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Targeted RNA Sequencing Revenue Market Share by Type (2020-2025)
Table 10. Global Targeted RNA Sequencing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Targeted RNA Sequencing Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Targeted RNA Sequencing Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Targeted RNA Sequencing Revenue Market Share by Application (2020-2025)
Table 15. Global Targeted RNA Sequencing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Targeted RNA Sequencing Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Targeted RNA Sequencing Application
Table 18. Global Targeted RNA Sequencing Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Targeted RNA Sequencing Market Share by Players (2020-2025)
Table 20. Global Top Targeted RNA Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted RNA Sequencing as of 2024)
Table 21. Ranking of Global Top Targeted RNA Sequencing Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Targeted RNA Sequencing Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Targeted RNA Sequencing, Headquarters and Area Served
Table 24. Global Key Players of Targeted RNA Sequencing, Product and Application
Table 25. Global Key Players of Targeted RNA Sequencing, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Targeted RNA Sequencing Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Targeted RNA Sequencing Revenue Market Share by Company (2020-2025)
Table 29. North America Targeted RNA Sequencing Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Targeted RNA Sequencing Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Targeted RNA Sequencing Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Targeted RNA Sequencing Revenue Market Share by Company (2020-2025)
Table 33. Europe Targeted RNA Sequencing Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Targeted RNA Sequencing Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Targeted RNA Sequencing Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Targeted RNA Sequencing Revenue Market Share by Company (2020-2025)
Table 37. China Targeted RNA Sequencing Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Targeted RNA Sequencing Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Targeted RNA Sequencing Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Targeted RNA Sequencing Revenue Market Share by Company (2020-2025)
Table 41. Japan Targeted RNA Sequencing Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Targeted RNA Sequencing Market Size by Application (2020-2025) & (US$ Million)
Table 43. South Korea Targeted RNA Sequencing Revenue by Company (2020-2025) & (US$ Million)
Table 44. South Korea Targeted RNA Sequencing Revenue Market Share by Company (2020-2025)
Table 45. South Korea Targeted RNA Sequencing Market Size by Type (2020-2025) & (US$ Million)
Table 46. South Korea Targeted RNA Sequencing Market Size by Application (2020-2025) & (US$ Million)
Table 47. Thermo Fisher Company Details
Table 48. Thermo Fisher Business Overview
Table 49. Thermo Fisher Targeted RNA Sequencing Product
Table 50. Thermo Fisher Revenue in Targeted RNA Sequencing Business (2020-2025) & (US$ Million)
Table 51. Thermo Fisher Recent Development
Table 52. Illumina Company Details
Table 53. Illumina Business Overview
Table 54. Illumina Targeted RNA Sequencing Product
Table 55. Illumina Revenue in Targeted RNA Sequencing Business (2020-2025) & (US$ Million)
Table 56. Illumina Recent Development
Table 57. Roche Holdings Company Details
Table 58. Roche Holdings Business Overview
Table 59. Roche Holdings Targeted RNA Sequencing Product
Table 60. Roche Holdings Revenue in Targeted RNA Sequencing Business (2020-2025) & (US$ Million)
Table 61. Roche Holdings Recent Development
Table 62. BGI Company Details
Table 63. BGI Business Overview
Table 64. BGI Targeted RNA Sequencing Product
Table 65. BGI Revenue in Targeted RNA Sequencing Business (2020-2025) & (US$ Million)
Table 66. BGI Recent Development
Table 67. Eurofins Company Details
Table 68. Eurofins Business Overview
Table 69. Eurofins Targeted RNA Sequencing Product
Table 70. Eurofins Revenue in Targeted RNA Sequencing Business (2020-2025) & (US$ Million)
Table 71. Eurofins Recent Development
Table 72. LabCorp Company Details
Table 73. LabCorp Business Overview
Table 74. LabCorp Targeted RNA Sequencing Product
Table 75. LabCorp Revenue in Targeted RNA Sequencing Business (2020-2025) & (US$ Million)
Table 76. LabCorp Recent Development
Table 77. Berry Genomics Company Details
Table 78. Berry Genomics Business Overview
Table 79. Berry Genomics Targeted RNA Sequencing Product
Table 80. Berry Genomics Revenue in Targeted RNA Sequencing Business (2020-2025) & (US$ Million)
Table 81. Berry Genomics Recent Development
Table 82. Macrogen Company Details
Table 83. Macrogen Business Overview
Table 84. Macrogen Targeted RNA Sequencing Product
Table 85. Macrogen Revenue in Targeted RNA Sequencing Business (2020-2025) & (US$ Million)
Table 86. Macrogen Recent Development
Table 87. GENEWIZ Company Details
Table 88. GENEWIZ Business Overview
Table 89. GENEWIZ Targeted RNA Sequencing Product
Table 90. GENEWIZ Revenue in Targeted RNA Sequencing Business (2020-2025) & (US$ Million)
Table 91. GENEWIZ Recent Development
Table 92. Targeted RNA Sequencing Market Trends
Table 93. Targeted RNA Sequencing Market Drivers
Table 94. Targeted RNA Sequencing Market Challenges
Table 95. Targeted RNA Sequencing Market Restraints
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Targeted RNA Sequencing Product Picture
Figure 2. Global Targeted RNA Sequencing Market Share by Type: 2024 VS 2031
Figure 3. Exome Sequencing Features
Figure 4. Enrichment Sequencing Features
Figure 5. Amplicon Sequencing Features
Figure 6. Global Targeted RNA Sequencing Market Share by Application: 2024 VS 2031
Figure 7. Research Institutes
Figure 8. Hospitals & Clinics
Figure 9. Biotechnology Company
Figure 10. Diagnostic Lab
Figure 11. Targeted RNA Sequencing Report Years Considered
Figure 12. Global Targeted RNA Sequencing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Targeted RNA Sequencing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Targeted RNA Sequencing Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Targeted RNA Sequencing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Targeted RNA Sequencing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China Targeted RNA Sequencing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Japan Targeted RNA Sequencing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. South Korea Targeted RNA Sequencing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. Global Targeted RNA Sequencing Market Share by Players in 2024
Figure 21. Global Top Targeted RNA Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted RNA Sequencing as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Targeted RNA Sequencing Revenue in 2024
Figure 23. North America Targeted RNA Sequencing Market Share by Type (2020-2025)
Figure 24. North America Targeted RNA Sequencing Market Share by Application (2020-2025)
Figure 25. Europe Targeted RNA Sequencing Market Share by Type (2020-2025)
Figure 26. Europe Targeted RNA Sequencing Market Share by Application (2020-2025)
Figure 27. China Targeted RNA Sequencing Market Share by Type (2020-2025)
Figure 28. China Targeted RNA Sequencing Market Share by Application (2020-2025)
Figure 29. Japan Targeted RNA Sequencing Market Share by Type (2020-2025)
Figure 30. Japan Targeted RNA Sequencing Market Share by Application (2020-2025)
Figure 31. South Korea Targeted RNA Sequencing Market Share by Type (2020-2025)
Figure 32. South Korea Targeted RNA Sequencing Market Share by Application (2020-2025)
Figure 33. Thermo Fisher Revenue Growth Rate in Targeted RNA Sequencing Business (2020-2025)
Figure 34. Illumina Revenue Growth Rate in Targeted RNA Sequencing Business (2020-2025)
Figure 35. Roche Holdings Revenue Growth Rate in Targeted RNA Sequencing Business (2020-2025)
Figure 36. BGI Revenue Growth Rate in Targeted RNA Sequencing Business (2020-2025)
Figure 37. Eurofins Revenue Growth Rate in Targeted RNA Sequencing Business (2020-2025)
Figure 38. LabCorp Revenue Growth Rate in Targeted RNA Sequencing Business (2020-2025)
Figure 39. Berry Genomics Revenue Growth Rate in Targeted RNA Sequencing Business (2020-2025)
Figure 40. Macrogen Revenue Growth Rate in Targeted RNA Sequencing Business (2020-2025)
Figure 41. GENEWIZ Revenue Growth Rate in Targeted RNA Sequencing Business (2020-2025)
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed
